A graphic nomogram for warfarin dosage adjustment

被引:11
作者
Dalere, GM
Coleman, RW
Lum, BL
机构
[1] Ctr Clin Canc Stanford, Clin Trials Off, Stanford, CA 94305 USA
[2] Palo Alto Vet Affairs Hlth Care Syst, Dept Pharm, Palo Alto, CA USA
[3] Kaiser Permanente Med Ctr, Dept Pharm, Santa Clara, CA USA
[4] Univ Pacific, Sch Pharm & Hlth Sci, Dept Pharm Practice, Stockton, CA USA
[5] Univ So Calif, Sch Pharm, Dept Clin Pharm, Los Angeles, CA USA
来源
PHARMACOTHERAPY | 1999年 / 19卷 / 04期
关键词
D O I
10.1592/phco.19.6.461.31038
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We assessed the ability of a graphic nomogram to adjust steady-state warfarin dosages and to predict international normalized :ratios (INR) after a dosage change, compared with an anticoagulation clinic pharmacist and a Bayesian regression computer program. Study subjects were 108 men and 3 women receiving warfarin anticoagulation. Tn all patients the median absolute errors in predicted INR values for the nomogram, computer program, and pharmacist were 0.33, 0.46, and 0.48, respectively. The nomogram was significantly more precise than both other methods (p=0.036). In a subset of 50 patients who required dosage reductions, the median absolute INR prediction errors for the nomogram, computer program, and pharmacist were 0.35, 0.54, and 0.48 respectively. The nomogram was significantly more precise than the pharmacist (p=0.005) and computer (p=0.002). The ability to provide more precise dosage reductions of warfarin may be of clinical importance in light of current recommendations for higher-intensity warfarin therapy and maintenance of higher INR values. Prospective validation of the performance of this nomogram in a routine clinical setting is warranted.
引用
收藏
页码:461 / 467
页数:7
相关论文
共 18 条
  • [1] ATRIAL-FIBRILLATION AND STROKE - 3 NEW STUDIES, 3 REMAINING QUESTIONS
    ALBERS, GW
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (13) : 1443 - 1448
  • [2] BUBP J, 1990, CLIN PHARMACOL THER, V47, P157
  • [3] RISK-FACTORS FOR COMPLICATIONS OF CHRONIC ANTICOAGULATION - A MULTICENTER STUDY
    FIHN, SD
    MCDONELL, M
    MARTIN, D
    HENIKOFF, J
    VERMES, D
    KENT, D
    WHITE, RH
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (07) : 511 - 520
  • [4] FREDRIKS DA, 1991, CLIN PHARMACY, V10, P923
  • [5] GLANTZ SA, 1987, PRIMER BIOSTATISTICS, P88
  • [6] HIRSH J, 1995, CHEST S, V108, P231
  • [7] An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
    Hylek, EM
    Skates, SJ
    Sheehan, MA
    Singer, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (08) : 540 - 546
  • [8] THE INTERNATIONAL NORMALIZED RATIO (INR) FOR MONITORING WARFARIN THERAPY - RELIABILITY AND RELATION TO OTHER MONITORING METHODS
    LE, DT
    WEIBERT, RT
    SEVILLA, BK
    DONNELLY, KJ
    RAPAPORT, SI
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (07) : 552 - 558
  • [9] LEE C, 1987, CLIN PHARMACY, V6, P406
  • [10] LEVINE MN, 1995, CHEST S, V108, P276